Is Medtronic 670g Waterproof?

Insulin Pump Rundown

Choosing an insulin pump doesn’t have to be an overwhelming process. Should you go with a more traditional pump where you can monitor your insulin levels directly? Are you looking for a model that works with a BGM monitor and allows you to administer insulin via a remote? Maybe you need a pump that offers integration with a CGM system. What about size? Color? To use tubes or not to use tubes? Presenting the options so you can find out what pump best fits your lifestyle is our goal. So, with several models on the market, let us help you sort through the choices by taking a look at what’s available and breaking down the various features of each. We’ve separated the pumps into four categories: pumps that incorporate or work with a Blood Glucose Monitor (BGM) and offer Continuous Glucose Monitoring (CGM), pumps with just CGM capability, pumps with just a BGM, and standalone pumps that don’t work with a BGM or offer CGM. Hybrid Closed-Loop System The 670 G system is the newest member to the Medtronic pump family and the first hybrid closed-loop system. In other ways, it is a like a “basal modulator” where you have to still bolus but it predicts your basal rate. Every 5 minutes, the auto-mode option (hybrid closed-loop) automatically adjusts basal insulin delivery based on your sugar levels to keep you range. It is excellent at catching lows because it stops your insulin dosage 30 minutes before you reach your pre-selected low limits, then it will automatically restart insulin when your levels recover. Possible concerns: excessive alerts and extended menu that needs clearing. Only approved for ages 14+ because it has a total daily dose requirement of at least 8 units a day. Feeling of loss of control of management with closed-loop system. Pumps with BGM and CGM ca Continue reading >>

Medtronic Announces Health Canada Licence Of The Minimed™ 630g System With New User-friendly Insulin Pump Design And Smartguard™ Technology

After interviewing more than 1,000 people with diabetes and testing user-experience, the enhanced features of the MiniMed 630G system were finalized to take into account what matters most to those with diabetes. This collaborative process with the patient community resulted in a new, user-friendly pump design that is waterproof[i] and features a high-definition, full-colour screen that supports easy navigation and enables increased customization with more intuitive menus. “We are excited to announce the launch of the MiniMed 630G system for Canadians living with diabetes. This latest innovation is a step towards Medtronic’s vision of transforming diabetes care and our commitment to providing improved outcomes and an improved user experience for our customers,” said Laura Cameron, Director of Diabetes & Consumer Care in Canada. The MiniMed 630G system combines its proprietary SmartGuard technology with a brand new user-friendly design. The new pump platform fully integrates continuous glucose monitoring (CGM) and SmartGuard technology, which is designed to trigger an alarm when the CGM sensor glucose level reaches a preset low limit and suspends insulin delivery if the user is unresponsive to the alarm. SmartGuard technology is the only feature available in Canada that takes action against lows[i] and is the only system proven to reduce the frequency of nighttime low episodes[ii] by a third.2,[iii] Data from the ASPIRE In-Home Study published in the New England Journal of Medicine2 demonstrated that SmartGuard technology not only reduces the number of low events2 per week by 30 percent but also shortens the length/intensity of those events at night by 37.5 % without increasing A1C (a measure of average blood sugar levels over three months).4 These results were vali Continue reading >>

An Update On Medtronic’s Minimed 670g System

This morning, the Medtronic Diabetes Group held a conference call for a small group of diabetes writers to give an update on its new MiniMed 670G system, otherwise known as the world’s first hybrid closed loop system. Louis Dias, Chief Patient Officer of Medtronic Diabetes and Mike Hill, Vice President of Marketing for Medtronic’s Intensive Insulin Management Business were both on the call, as was Karrie Hawbaker, Senior Manager of Social Media. First, a recap on what the system is and what it does: The MiniMed 670G system is a combination of an insulin pump and a continuous glucose monitor. What sets it apart from its predecessors—and, for that matter, every other pump on the market—is that it can actually give you insulin. This makes it a major step forward toward the goal of a truly closed loop system. How does the 670G system work? Users must program their insulin-to-carb ratios, calibrate the system twice a day with a blood glucose reading from a finger stick, and give the system a “meal announcement” when they’re about to eat by entering the number of grams of carbohydrate that they intend to consume. The system then uses the grams of carbohydrate users have entered and their insulin-to-carb ratio to estimate an initial bolus to cover the meal. In the hours that follow, the system makes tiny tweaks to basal rates in order to get blood sugar levels as close as possible to 120 mg/dL. This means that you don’t need to enter correction boluses and that there’s no longer such thing as dual wave or square boluses—the pump is taking care of it for you. How’s it different from the most recent MiniMed pump? Medtronic Diabetes’s current top-of-the-line pump is the MiniMed 630G system with Enlite Sensor. The 530G uses something called SmartGuard™ te Continue reading >>

Medtronic Is Leading Innovation In Diabetes Technology

by Bonnie Goldberg, MA, RD, CDE Bonnie is a Registered Dietitian with a Masters Degree in Health Education from Columbia University. She specializes in diabetes care and has spent her career educating and empowering people with diabetes. She is proud to currently work for Medtronic. At Medtronic, we’re proud to introduce two new members of the MiniMed family—the MiniMed® 670G sytem and the MiniMed® 630G system. On September 28, the FDA approved the world’s first hybrid closed loop insulin delivery system. This brand-new system automates basal insulin delivery based on the personalized needs of the user, maximizing the time glucose levels are within the target range. It is designed to learn what an individual’s insulin needs are and to take action to minimize the time people with type 1 diabetes have both high and low glucose levels. The system also features the latest in continuous glucose monitoring (CGM) with the Guardian® Sensor 3, our newest and most advanced glucose sensor with enhanced accuracy and performance, a longer 7-day life. It is also the first and only sensor approved by the FDA to control a hybrid closed loop system. The MiniMed 670G system will be commercially available spring of 2017 as Medtronic ensures market and manufacturing readiness, patient access, and appropriate employee, clinician, and patient training. In the meantime, we also launched the brand-new MiniMed 630G system in August 2016. That’s right, the #1 most prescribed insulin pump system has been completely redesigned with a fresh new look, added capabilities, and a simplified user interface. So, what’s new in the MiniMed 630G system? Color Screen The MiniMed 630G insulin pump has a bright, high-contrast color screen that adjusts automatically to suit in the light in your e Continue reading >>

Nicky Answers Your Questions About The Minimed 670g System

I’ve met a lot of inspiring people with diabetes. But when I was lucky enough to meet Nicky, this 17-year-old who plays soccer, hikes mountains, rides horses, excels in school and is a working through an ambitious “1000 places to see” list, I was wowed. Talk about someone not letting diabetes hold her back. She’s also been using the MiniMed® 670G system for more than a year as a clinical trial participant and kindly volunteered to let us share her story in photos, video and more. We know you’re all curious to hear what the new system is like in the real world, so we recently asked our social community what you’d like to ask Nicky. Today, she’s answering your questions! Diabetes is hard for anyone, but as a busy teenager who just wants to go have fun with friends it can be extremely hard to take care of both. However because my MiniMed 670G system is capable of helping me take care of diabetes, it allows me to focus on being a teenager rather than a diabetic. My favorite part of the system is how confident the pump, especially the Auto Mode feature, makes me in my diabetes. It takes care of most of my blood sugar fluctuations without me having to even think about it. And I know that if anything even starts to go wrong with my sensor glucose then it will notify me so that I will have plenty of time to deal with it. Because of this it has definitely become an essential part of my busy life. I have tried to go a few days without the system, and have noticed that I am much more anxious throughout the day because I do not have that extra help from the system and have noticed that my blood sugars are much worse on those days. How does the pump operate during a sensor warm up, and how does the system work if something goes wrong with your sensor? Is there a defau Continue reading >>

670g Waterproof Question : Diabetes

Has anyone w/ a 670G gone swimming with their pump on? I just got mine up-and-running last week and am wondering if I should go swimming with it? I read that it is waterproof up to 12 ft of water for 24 hours, but that you should consider taking it off when you absolutely KNOW that you're going to be in the water. Moreso that it won't be completely ruined if you should happen to get it submerged for whatever reason ON ACCIDENT. It would be awesome to not have to take it off to go swimming for a few hours, but I definitely don't want to take any risks over the long run. Continue reading >>

King City Rustler | Local Diabetes Patients Among First To Receive Automated Insulin Delivery

Local diabetes patients among first to receive automated insulin delivery SALINAS Patients with Type 1 diabetes at the Salinas Valley Medical Clinic Diabetes and Endocrine Center are among the first in the world to have access to a revolutionary new FDA approved device. The MiniMed 670G was developed by Medtronic and is a hybrid closed loop system. The device is roughly the size of a credit card that a person wears outside the body and continuously monitors glucose levels and delivers insulin 24 hours a day based on the personal needs of the patient. Salinas Valley Medical Clinic is one of just 60 sites in the world chosen for pre-release of this device, and one of five places in California able to offer the MiniMed 670G to its patients. The Diabetes and Endocrine Center received pre-release status due to its expertise in the excellent treatment of diabetes. This is a revolutionary device, it will change peoples lives, says Dana Armstrong, RD, CDE, director of Diabetes Services at Salinas Valley Medical Clinic. People with Type 1 diabetes who are now using this device no longer have to inject themselves with insulin, the device is doing it for them whenever it senses insulin is needed. Its making the management of Type 1 diabetes easier. The Food and Drug Administration (FDA) approved the MiniMed 670G in September 2016. It is only for treatment of people with Type 1 diabetes 14 years of age and older. Rebecca Bishop, a Type 1 diabetes patient at the Salinas Valley Medical Clinic Diabetes and Endocrine Center is one of a few people in California and throughout the world now using the MiniMed 670 G System. Bishop is 54 years old and was diagnosed with diabetes as a child. Diabetes is an ever consuming disease, its always on your mind, says Rebecca Bishop. You always have Continue reading >>

Hybrid Closed Loop System.

NEW! The Suspend before low§ option avoids lows and rebound highs proactively by automatically stopping insulin 30 minutes before you reach your pre-selected low limits, then automatically restarts insulin when your levels recover, all without bothersome alerts. NEW! The Auto Mode‡ option automatically adjusts your basal insulin delivery every 5 minutes based on your sugar levels to keep you in target range, all day and night. Watch Video View Brochure Get Started NEW! Guardian® Sensor 3 continuous glucose monitoring sensor. Introducing the most accurate sensor from Medtronic, now with up to 7 day wear and easy insertion. It is the FIRST and ONLY continuous glucose monitoring sensor FDA approved and trusted to control insulin dosing. Exclusive CONTOUR®NEXT LINK 2.4 meter1 Get easy and accurate CGM calibration, insulin dosing and remote bolusing with our exclusive meter. “This device will mean peace of mind, in knowing a person will be in normal blood sugar range a great majority of the time,” “It’s a medical device with the potential to change the lives of more than 1 million Americans who suffer from Type 1 diabetes.” KEEP YOUR GLUCOSE IN RANGE SMARTGUARD® HCL TECHNOLOGY. Quick and easy access to your glucose and insulin information, all from the home screen. Bright color screen for easy readability - day or night. Waterproof - so you can enjoy underwater activities. Quick and easy bolus from your meter. Fewer shots than multiple daily injections. The only sensor FDA approved and trusted to control insulin dosing. Easy to insert. Know at all times where your glucose levels are trending. Click here for assistance if your insurance does not currently cover the MiniMed 670G system. * Mean Absolute Relative Difference. ** 3-4 calibrations per day required. Continue reading >>

Fda Approves Medtronic’s Minimed 630g System, Ships In September

By Brian Levine and Adam Brown Adds waterproof, color screen, and remote meter bolus. Will it speed FDA review of the 670G hybrid closed loop? Earlier this month, Medtronic unexpectedly announced FDA approval of the MiniMed 630G. This pump offers the same threshold (low glucose) suspend algorithm as the MiniMed 530G with Enlite, but on the company’s next-gen pump platform – adding a color screen, waterproofing, remote bolusing from the Contour Next Link glucose meter, more alarm customization, insulin on board displayed on the home screen, and other key improvements listed in the table below. The pump is approved for people 16 years and up and will begin shipping in September. Medtronic has more information posted on its website. There was a lot of confusion in the diabetes community about this product and why it is launching, so some common questions are answered below. Can current Medtronic pumpers upgrade to the 630G? Yes, but it is pricey and not covered by insurance if the pump being upgraded is less than four years old. The out of pocket cost to upgrade to the 630G is $599 for Medtronic pumps purchased after May 1, 2016 and $3,100 for pumps purchased before May 1, 2016 (assuming the old pump is sent in to Medtronic). Current MiniMed 530G/Enlite users who want the 630G’s Enlite CGM integration will also need to buy a new transmitter for $511. How does this compare to the 640G (predictive low glucose suspend) available in Europe and the MiniMed 670G (hybrid closed loop) under FDA review? The MiniMed 630G is the same pump platform as the 640G and 670G, meaning it has the same overall pump body design, waterproofing, screen, buttons, etc. However, the 630G has the simplest control algorithm in it: suspending basal insulin delivery when the low threshold is cross Continue reading >>

The Future Of Diabetes: My 3 Weeks On A Bionic Pancreas

The Future of Diabetes: My 3 Weeks on a Bionic Pancreas First, whats the status of the race towards an artificial pancreas? Ive been quietly watching from the sidelines for nearly the past two years as work on artificial pancreas algorithms and hardware has gotten much closer to becoming reality. Excitingly, we are now just under two years from having a wide selection of artificial pancreas options on the market! (pending FDA approval of course) The soonest looks like it will be Medtronics MiniMed 670G hybrid closed-loop system , which is currently in pivotal trials (pivotal or Phase 3 trials are the phase required by the FDA before devices can be marketed and sold to the public), with a potential launch in April 2017. Following closely is TypeZeros inControl system . Tandem , Insulet (of OmniPod fame and the only tubeless artificial pancreas trial device Im aware of), Bigfoot Biomedical and Beta Bionics are all aiming for pivotal trials in 2017 and would therefore potentially launch in 2018. Short of a cure, the release of these products is something Ive dreamed about for years. No longer having to check my blood sugar 8 to 12 times per day. No longer having to precisely measure the carbohydrate content of my food. No longer having to painstakingly calculate the correct carb:insulin ratio. And no longer having to worry as much about what I eat in general and constantly have to think about diabetes. I was lucky to hear about a study going on at Stanford for the artificial pancreas about 6 months ago and ended up taking part in a trial for the Beta Bionics version. Thats the same Beta Bionics, led by Ed Damiano, which just secured $5M for the planned 2017 pivotal trial to take their iLet Bionic Pancreas to market. If you dont know the Beta Bionics story, Ed gave an exce Continue reading >>

The Minimed 640g Insulin Pump With Smartguard®

Our MiniMed 640G System combines: Advanced protection Personalised convenience Improved design The MiniMed system can guide you towards better control1 by providing advanced protection from hypoglycaemic episodes2 and personalised convenience for easier daily management of your diabetes. ADVANCED PROTECTION Tired of experiencing unexpected lows? Worried about hypos? To avoid low glucose levels and maintain good glucose control, it is important to know where your glucose levels are and where they are heading. The MiniMed 640G system is designed to help protect you, so you can feel more secure. SmartGuard®, our exclusive technology, mimics some functions of a healthy pancreas to provide advanced protection against hypoglycaemia.4* Based on your sensor glucose values, SmartGuard® can predict when you are approaching low glucose levels 30 minutes in advance and automatically stop insulin delivery** When your glucose levels recover, SmartGuard will automatically resume insulin delivery***. You have the possibility to set multiple low limits throughout the day to give you increased protection when you need it most. Dynamically stopping insulin delivery with a suspend feature can significantly reduce the number of hypoglycaemic events.4 93% of those who used a suspend feature in their pump felt more secure managing their diabetes.5 Find out more about our exclusive SmartGuard technology for advanced protection in this video. Active insulin tracking, so the insulin still working in your body is displayed on the pump screen and taken into account in the Bolus Wizard® recommendation Bolus progress bar, allowing you to see the amount of bolus insulin being delivered; and Stop Bolus, to easily stop a bolus at any time Predictive battery end of life, so you know when your battery Continue reading >>

Newsflash: Medtronic Launches New Minimed 630g System

A new Medtronic insulin pump is now available in the United States, introducing a new des ign and color-screen as part of a complete makeover to these diabetes devices that have fundamentally looked the same for 30 years! Say hello to the Minimed 630G, which Medtronic announced on Thursday after receiving the FDA's Pre-Market Approval on Aug. 10. This news caught many by surprise, as the California pump-CGM company hadn't previewed this product in advance as they typically do before launches. Instead, they've focused on their forthcoming 670G hybrid closed loop system, expected to be the first-gen commercial Artficial Pancreas system to hit market in 2017. A number of users are actually upset that they weren't warned of this interim product launch, because they've recently purchased new products or upgrades. Others were holding out for the future closed loop system. So we're all wondering: Just what is this 630G that we've heard nothing about before? Remember, Medtronic got FDA approval in September 2013 for its 530G that automatically stops insulin delivery once a user crosses a certain low glucose level. That was step one in moving toward closed loop technology. Next up is their Predictive Low Glucose Suspend (PLGS) features that can anticipate oncoming hypos in advance and shut off insulin to prevent them from happening. That's built into the Minimed 640G system that hit the market outside the U.S. in early 2015. Medtronic ultimately decided it would not pursue bringing that device to the U.S., opting instead to leapfrog that model and focus on getting the first hybrid closed loop 670G to market in 2017. So now, it seems we're getting this 630G as a sort of stop-gap device in between the two D-tech generations. Here's a quick glance at the Minimed 630G: Fresh Design: Continue reading >>

Your Questions Answered: The Minimed 670g System

In September, the FDA approved a big leap forward in diabetes technology, the world’s first hybrid closed loop system. The MiniMed® 670G system is designed for people with type 1 diabetes who are 14 and older. Having been diagnosed with type 1 in 1989, when blood glucose meters were bigger than the current larger iPhone, this seems amazing! The Glu team recently connected with Chief Patient officer Louis Dias about the reveal of the highly anticipated MiniMed 670G product. Let’s hear what he had to say! GluAnna: Why is the MiniMed 670G system such an important innovation in today’s world? Louis: This system is important because it has the potential to dramatically change the way individuals and families deal with the highs and lows of diabetes. What we heard from so many of the people who participated in the clinical trial was how different it made them feel both physically and emotionally, giving them that peace of mind that can be so elusive in a life with diabetes. GluAnna: That’s great! So what is new about this particular model that patients can expect from either older models or users brand new to pump therapy? Louis: If you have the product in hand, you now have the opportunity to put the device in Auto Mode, where the pump automatically adjusts the delivery of your basal insulin based on readings from our most advanced CGM sensor, called the Guardian® Sensor 3. Auto Mode works to keep you at 120 mg/dl. Instead of you always making the adjustments, testing different basal rates and basal patterns to try to match the amount of insulin you need for different times of day and activities, about every 5 minutes the system determines how much insulin to give you, based on the sensor reading – taking more than a few math problems off of your plate. It also g Continue reading >>

Meet The Minimed™ 630g System

PREDICTIVE ALERTS The pump lets you know up to 30 minutes ahead if you’re trending high or low, so you can act sooner to keep your glucose levels where you want them. Continuous Glucose Monitoring (CGM) The sensor wirelessly sends glucose information to your pump every five minutes, so you can see how you’re doing, spot trends and make adjustments. * CGM uses a special sensor to measure sugar levels just below the skin known as interstitial fluid. These sensor glucose (SG) values are different from blood glucose (BG) measurements using a BG meter. Sensor glucose values should not be used to make treatment decisions. Patients should always do a BG fingerstick before they make treatment decisions. ** The Bolus Wizard calculator does not account for manual injections and could prompt you to deliver more insulin than needed. Too much insulin may cause hypoglycemia. Consult with your healthcare professional for how long you need to wait after a manual injection before you can rely on the active insulin calculation of your Bolus Wizard calculator. OTHER BENEFITS OF THE MINIMED 630G INSULIN PUMP § The MiniMed™ 630G insulin pump is waterproof in up to 3.6 meters (12 feet) of water for up to 24 hours. The Guardian™ Link transmitter is waterproof in up to 2.4 meters (8 feet) of water for up to 30 minutes. See product user guide for care instructions to help maintain waterproof. EXCLUSIVE SMARTGUARD TECHNOLOGY FOR BETTER GLUCOSE CONTROL Insulin pump technology with SmartGuard technology makes it easier to stay in range. You’re four times more likely to reach your target A1C and you can also reduce low glucose episodes by up to 84 percent and lower the risk of long-term complications.1, 2 1. Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term Continue reading >>

Medtronic Minimed® 670g Insulin Pump System

The MiniMed® 670G Insulin Pump System is the first hybrid closed loop (HCL) system. This system offers the most advanced SmartGuard® HCL technology, with two new levels of personalization. Manual Mode with the Suspend Before Low feature automatically stops insulin 30 minutes before pre-selected low limits, then restarts once insulin levels recover. Auto Mode continuously reads sensor glucose values and automatically adjusts basal insulin every 5 minutes. Guardian Sensor® 3 provides up to 7 days of wear Waterproof design with user-friendly color screen and simple menu Built-in CGM allows for wireless transmittal of glucose information every five minutes Bolus Wizard® makes it easier to calculate mealtime insulin and may avoid insulin stacking CCS Medical offers Ascensia Diabetes Care strips for use with Medtronic pumps for many insurance plans. Continue reading >>